{"id":2066,"date":"2018-07-03T08:46:09","date_gmt":"2018-07-03T06:46:09","guid":{"rendered":"https:\/\/alzheimer.noemi.lu\/?p=1659"},"modified":"2018-07-03T08:46:09","modified_gmt":"2018-07-03T06:46:09","slug":"congratulations-to-vumc-the-epad-trial-delivery-centre-of-the-month","status":"publish","type":"post","link":"https:\/\/ep-ad.org\/index.php\/2018\/07\/03\/congratulations-to-vumc-the-epad-trial-delivery-centre-of-the-month\/","title":{"rendered":"Congratulations to VUmc, the EPAD Trial Delivery Centre of the Month"},"content":{"rendered":"<p>We are delighted to announce that\u00a0<strong>80 new research participant<\/strong>s were enrolled in the EPAD Longitudinal Cohort Study (LCS) in\u00a0<strong>June<\/strong>. We were thus able to continue the positive trend of increasing recruitment on a monthly basis, as it made June our most successful month to date\u00a0 exceeding the 75 research participants enrolled in May and the 73 in April.<\/p>\n<p>Congratulations are due to <a href=\"https:\/\/www.alzheimercentrum.nl\/\">VUmc\u00a0(Amsterdam, Netherlands)<\/a> as the team screened 15 research participants in June for their inclusion in the EPAD study making it the most successful centre this month.\u00a0Congratulations to the whole team (pictured above at the General Assembly meeting in Amsterdam with\u00a0Lisa Vermunt, Silvia Ingala, Pieter-Jelle Visser and Philip Scheltens missing in the photo).<\/p>\n<p>Philip Scheltens, Director of the Alzheimer Centre was delighted by the success of his team: &#8220;The\u00a0EPAD project will create the largest trial ready cohort for early stage AD trials in the world. Its setup and design, in combination with the proof of concept studies that will start next year, makes it a unique and rich source of relevant patient data. We at VUmc are thrilled to be a part of EPAD and consider it our duty to be frontrunner in inclusion. We expect our patients are anxious to start the first trial with new compounds and so are we.&#8221;<\/p>\n<p>A special mention this month goes to Jos\u00e9 Luis Molinuevo&#8217;s team in Barcelona (Spain) who recruited 11 new research participants.<\/p>\n<p>We are also pleased to have reached an exciting new milestone with over 800 screened research participants.\u00a0<strong>Stay tuned for more news after the summer break in early September!<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><a class=\"dt-single-image\" href=\"https:\/\/ep-ad.org\/wp-content\/uploads\/2015\/07\/Logo-Vumc-1.png\" rel=\"attachment wp-att-1647\"><img decoding=\"async\" class=\"size-medium wp-image-1647 aligncenter\" src=\"https:\/\/alzheimer.noemi.lu\/wp-content\/uploads\/2015\/07\/Logo-Vumc-300x62.png\" alt=\"Logo Vumc\" width=\"300\" height=\"62\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are delighted to announce that\u00a080 new research participants were enrolled in the EPAD Longitudinal Cohort Study (LCS) in\u00a0June. We were thus able to continue the positive trend of increasing recruitment on a monthly basis, as it made June our most successful month to date\u00a0 exceeding the 75 research participants enrolled in May and the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2068,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-2066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/2066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/comments?post=2066"}],"version-history":[{"count":0,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/2066\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media\/2068"}],"wp:attachment":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media?parent=2066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/categories?post=2066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/tags?post=2066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}